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ABSTRACT  
 
Babies on the neonatal unit are often exposed to a number of noxious stimuli.  
Procedures such as venepuncture, insertion of cannulae, heel prick and 
endotracheal ventilation can occur on a daily basis, and the majority of these babies 
do not receive any pain relief treatment.  Current methods of assessing pain in 
neonates, comprising behavioural cues and physiological markers, can be difficult to 
relate directly to pain perception, especially in preterm infants, as they can also be 
indicative of other states such as stress, anxiety and hunger.  Accurate recognition of 
pain in a neonate could enable more appropriate use of analgesics, thereby reducing 
morbidity and limiting potential side-effects.  
 
We investigated 48 babies using techniques that may evaluate the function of 
nociceptor-specific nerve fibres and central pain pathways, in comparison with 
currently used behavioural and physiological indicators. These techniques included 
“objective” physiological responses to procedural pain, such as skin axon-reflex 
vasodilatation (flare) responses, and novel contact cerebral evoked potentials in 
response to warm (non-painful) stimuli.  
 
We recorded physiological responses (i.e. sweat rate, changes in blood flow, 
sympathetic skin response) during clinically required heel prick procedures in babies 
on the neonatal unit.  Palmar sweat rate was higher in babies ≥ 36 weeks, and 
significantly correlated with gestational age. We did not see any relationship between 
the painful heel prick procedure and palmar sweat response. We were unable to 
demonstrate any increase in the sympathetic skin response waveforms post-heel 
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prick procedure in the one baby we studied.  Changes in local skin blood flow around 
the heel prick (ipsi-lateral limb) and in the opposite foot (contralateral limb) were very 
variable, although many babies showed an increase in the blood flow post-heel prick.  
We also performed a behavioural analysis (using PIPP) during heel prick procedures 
in babies whilst simultaneously recording their palmar sweat levels. We could not 
demonstrate any definite association between the palmar sweat response to pain 
and the PIPP scores.  
 
The feasibility of recording warm temperature induced cerebral evoked potentials in 
neonates was investigated, using scalp EEG electrodes, in response to a cutaneous 
stimulus with a thermode destination temperature 37°C.  However, the EEG 
waveforms were obscured by ocular artefact, and thus warm temperature evoked 
potentials could not be demonstrated in neonates, unlike adults. 
 
In conclusion, current methods of behavioural and physiological assessment of pain 
in neonates have an important role, but are not specific and unlikely to be helpful in 
monitoring the effects of new analgesics.  Warm stimuli evoked cerebral potentials 
are technically difficult to record in neonates, and heat pain stimuli are unjustified, 
but other techniques such as functional MRI may provide a useful measure and 
deserve study.  The assessment and treatment of pain in neonates remains a major 
unmet clinical need.      
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INTRODUCTION 
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1.1 PAIN 
1.1.1 DEFINITION 
International Association for the Study of Pain (IASP) defines pain as "an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, 
or described in terms of such damage" (Loeser and Treede 2008).  As per this 
definition, pain is said to be subjective and best assessed by self-report which is not 
possible in neonates. Nociception is defined as "the neural processes of encoding 
and processing noxious stimuli” (Loeser and Treede 2008). The term nociception 
was coined by Charles Scott Sherrington in 1906. 
1.1.2 PATHOPHYSIOLOGY OF PAIN 
 
Sensation of pain is elicited by a stimulus that causes or can potentially cause tissue 
damage. Nociceptors are free nerve endings that have their cell bodies in the dorsal 
root ganglia. After transduction of the first noxious stimuli into action potentials in the 
afferent neuron, a series of changes occur in components of the pain pathway that 
alter the way these components respond to subsequent stimuli. Both increased and 
decreased sensitivity to painful stimuli can occur. The term ‘hyperalgesia’ is used to 
describe a condition when these changes result in an increased sensitivity to painful 
stimuli. The term ‘analgesia’ is used to describe selective suppression of pain without 
effects on consciousness or other sensations. Pain differs significantly from other 
somatosensory modalities in that it can be altered by past experiences, suggestion, 
emotions and the simultaneous activation of other sensory modalities. Thus the level 
of pain experienced is not solely a physical property of the stimulus (Eric P. 
Widmaier 2006). 
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There are two major somatosensory pathways, the anterolateral pathway and the 
dorsal column pathway.  
 
The ascending anterolateral pathway (spinothalamic tract) is responsible for 
transmission of pain and temperature to the brain. It makes its first synapse between 
the sensory receptor neuron and a second neuron located in the gray matter (dorsal 
column) of spinal cord (Eric P. Widmaier 2006). Two types of nociceptor fibres have 
been identified: the myelinated Aδ fibres carry signals faster (2.5–35 m/s) than the 
unmyelinated C fibres (0.5–2.0 m/s). Pain evoked by the Aδ fibres is described as 
sharp, acute, pricking pain and is felt first. This is followed by a duller poorly localised 
pain, often described as burning, aching or throbbing pain that is carried by the C 
fibres (Craig 2003). The axons of these neurons travel up the spinal cord to the brain 
and cross the midline through the anterior white commissure, passing upwards in the 
contralateral anterolateral columns. The second order neuron projects through the 
anterolateral column of the cord to the thalamus, where it synapses on cortically 
projecting neurons. As the pathways cross from the side where the afferent neurons 
enter the central nervous system to the opposite side in the spinal cord, the sensory 
pathways from somatic receptors on the left side of the body go to the 
somatosensory cortex of the right cerebral hemisphere. Pain-related activity in the 
thalamus relays to the insular cortex and anterior cingulate cortex, and pain that is 
distinctly located also activates the primary and secondary somatosensory cortices 
(Romanelli and Esposito 2004). In the somatosensory cortex, the endings of the 
axons of the specific somatic pathways are grouped according to the peripheral 
location of the receptors that give input to the pathways(Eric P. Widmaier 2006).  
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When the signals are sent to the reticular formation and thalamus, the sensation of 
pain enters consciousness in a dull poorly localized manner. From the thalamus, the 
signal can travel to the somatosensory cortex in the cerebrum, when the pain is 
experienced as localized and having more specific qualities. Nociception can also 
cause generalized autonomic responses before or without reaching consciousness 
to cause pallor, diaphoresis, tachycardia, hypertension, light headedness, nausea 
and fainting (Feinstein, Langton et al. 1954). 
 
 
Image 1.1: The Pain Pathway (adapted from 
http://grants.hhp.uh.edu/clayne/6397/Unit5.htm) 
23 
 
In the central nervous system, monoamines, catecholamines and neuropeptides are 
all thought to act as neurotransmitters or neuromodulators and have been implicated 
in the pain pathways (Ruda et al. 1987). The nociceptors are activated by 
mechanical, thermal or chemical stimulation. The arachidonic acid pathway produces 
the inflammatory mediators involved in the pain pathway, namely the prostaglandins, 
leukotrienes and thromboxanes.  The prostaglandins and leukotrienes sensitize the 
nociceptors to other inflammatory mediators (like bradykinin and histamine) which 
interact with substance P (a neuropeptide released from the peripheral neurons) to 
stimulate the nerve endings. Substance P also stimulates mast cells to release more 
histamine as well as more prostaglandins and bradykinins, further stimulating the 
nociceptors.  Substance P is also known to contribute to swelling and redness in the 
area of pain (Yudcovitch LB, adapted from 
http://www.pacificu.edu/optometry/ce/courses/22746/ocularpainpg1.cfm). 
 
 
Image 1.2: Physiological pathway of pain (adapted from 
http://instruct1.cit.cornell.edu/courses/psych396/student2006/ 
the_biology_of_pain_ mac_version/receptor2.jpg) 
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1.1.3 PAIN PATHWAYS IN THE NEWBORNS 
 
Development of neural pathways has been studied in human infants using 
histological studies. It was previously thought that neonates did not perceive any 
noxious stimuli as unpleasant, and even if they felt pain they probably did not 
remember it in the long term. Contrary to this belief, we now know that the pathways 
responsible for conducting pain signalling up to the brain have developed by 20-24 
weeks of gestation and the pathways that inhibit incoming pain impulses do not 
mature until the last trimester of pregnancy. The first cutaneous sensory receptors 
have been found between 7.5 and 10.5 weeks gestational age. The primary 
nociceptive afferents synapse with the spinal cord neurons at around 19 weeks. 
Even though the thalamic projections to the cortical plate occur at 22 weeks, the true 
connections to the cortex are thought to develop between 21 and 28 weeks 
gestational age (Anand and Hickey 1987; Anand and Carr 1989; Fitzgerald 1991).    
 
In foetal life, presence of large receptive fields in the sensory neurones in the spinal 
cord along with diffuse central connections are likely to lead to poorer discrimination 
between noxious and non-noxious events and poorer spatial localisation (Fitzgerald 
1991; Lloyd-Thomas and Fitzgerald 1996). Also, the descending inhibitory system of 
afferent neurons does not develop until after birth, resulting in large receptive fields 
and prolonged responses to stimuli during neonatal period (Anand and Carr 1989; 
Schechter NL 1993; Andrews and Fitzgerald 1994). This may increase the pain 
sensitivity of infants born prematurely by lowering the threshold of pain perception 
and make them more susceptible to pain (Craig, Whitfield et al. 1993; Johnston, 
Stevens et al. 1995; Giannakoulopoulos, Teixeira et al. 1999; Franck, Greenberg et 
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al. 2000; Smith, Gitau et al. 2000; Vanhatalo and van Nieuwenhuizen 2000; Gunnar 
and Quevedo 2007). 
 
Having known the chronological order of the appearance of these pathways, mere 
anatomical presence of these does not necessarily mean that they are functionally 
active as well. As the somatosensory system continues to evolve and grow even 
after birth, it is still unclear whether neonates have the ability to discriminate between 
sensory and other type of stimuli, as do adults.  
 
1.1.4 PAIN IN NEONATES – THE PROBLEM 
 
Unrecognised and under-treated pain remains a major issue of concern in Neonatal 
Intensive Care Units.  With advances in neonatal and obstetric care, the survival  
of extremely preterm neonates has increased over the past two decades. As a  
result, the number of painful procedures that neonates undergo has also multiplied.  
During hospitalisation in a Neonatal Unit, babies may undergo between 2 and 14  
invasive, potentially painful procedures each day and up to 100 in first 14 days of  
hospitalisation, for which less than one in three receive an analgesic therapy 
(Johnston, Collinge et al. 1997; Simons, van Dijk et al. 2003; Carbajal, Rousset et al. 
2008). Babies undergo a number of different procedures like heel prick, intubation, 
endotracheal suctioning, intravenous cannulation, arterial lines placement etc, the 
most common being endotracheal suctioning and heel prick sampling (Barker and 
Rutter 1995; Johnston, Collinge et al. 1997; Porter FL 1998; Benis MM 2001; 
Simons, van Dijk et al. 2003). Most of these procedures are done in the first 24-48 
hours of admission. 
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1.1.5 PAIN IN NEONATES – WHY BOTHER? 
 
As well as ethical consideration of having babies suffer pain, there is evidence to 
support adequate analgesia in reducing long term morbidity. Pain can adversely 
affect both short term and long term outcomes of babies (Porter, Grunau et al. 1999; 
Anand 2000). Repeated exposure to painful stimuli may alter babies’ physiological 
responses, hormone levels and stimulate HPA - axis in a group of population whose 
nervous system is still developing (Grunau, Holsti et al. 2005; Grunau, Haley et al. 
2007). These changes may result in tissue injury and increase the risk of IVH and 
PVL (Hall, Kronsberg et al. 2005). These painful experiences could adversely affect 
the neuro-developmental outcomes (Grunau, Holsti et al. 2006). Studies have shown 
that following a stimulus such as peripheral tissue injury, there is a reduction in the 
threshold of the nociceptive specific neurones in addition to the increase in the 
excitability of the central nervous system (Woolf 1983). An increased response to 
pain was shown following a higher frequency of painful procedures in low birth 
weight neonates at 32 weeks as compared to controls (Grunau, Oberlander et al. 
2001). These may result in prolonged states of hyperalgesia and cutaneous 
hypersensitivity (Fitzgerald and Walker 2009). These studies have shown that infants 
exposed to multiple painful procedures earlier in life showed greater pain response 
than babies who were exposed to fewer painful stimuli. There is also evidence 
showing that untreated procedural pain results in adverse long term cognitive, 
behavioural and emotional consequences (Grunau 2002; Klein, Gaspardo et al. 
2009). Helleurd and Storm (2002), in their study showed that non-painful sensory 
stimulation of infants (especially preterm and early newborns) can produce equal or 
higher levels of physiological stress activation than painful stimulation and that 
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repeated nociceptive stimulation probably sensitises the infants to pain (Hellerud and 
Storm 2002).  
 
We, therefore, have physiological, moral and ethical reasons for prevention, 
assessment and treatment of pain in neonates.  
 
1.1.6 ASSESSMENT OF PAIN IN NEONATES 
 
Recognition and treatment of pain can still be termed a ‘gray zone’ in Neonatal 
Intensive Care Units. In spite of advances in all other aspects of neonatal care, huge 
knowledge gaps still exist in the area of assessment and management of pain. 
Unlike adults, babies cannot communicate verbally and rely on their caregivers for 
the assessment and treatment of their pain.  Current methods of assessing neonatal 
pain include both behavioural cues (like facial expressions, crying and body 
movements) and physiological markers (autonomic responses such as heart rate, 
respiratory rate and oxygen saturation).  Based on these parameters, more than 40 
different pain scores are currently in use all around the world (Ranger, Johnston et 
al. 2007). However, these parameters are very non-specific and can sometimes be 
difficult to attribute directly to pain, as they can also be indicative of other states such 
as agitation, stress, anxiety and hunger and could be altered by babies’ neurological 
state and use of medication. At present less than 20% of the neonatal units in the UK 
have a pain assessment protocol (Redshaw M 2005).  
 
In the last two decades, numerous studies have been done looking at pain 
transmission in neonates and its management. These include: 
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1. Behavioural responses (Grunau and Craig 1987; Johnston, Stevens et al. 
1995; Grunau, Oberlander et al. 1998; Slater, Fitzgerald et al. 2007). 
 
2. Physiological responses: 
 Skin blood flow (McCulloch, Ji et al. 1995; Kunzek, Quinn et al. 1997). 
 Sweat rate (Verbov and Baxter 1974; Harpin and Rutter 1982a; Harpin 
and Rutter 1982b). 
 Skin conductance (Roeggen, Storm et al. ; Storm 2000; Hellerud and 
Storm 2002; Hernes, Morkrid et al. 2002; Storm, Myre et al. 2002; 
Harrison, Boyce et al. 2006). 
 
3. Changes in total haemoglobin concentration in cerebral cortex (NIRS) (Baird, 
Kagan et al. 2002; Pena, Maki et al. 2003; Taga, Asakawa et al. 2003; Slater, 
Cantarella et al. 2006). 
 
4. Evoked potentials to noxious heel prick stimuli (Slater, Cantarella et al. 2006; 
Slater, Fitzgerald et al. 2007; Slater, Fabrizi et al. 2010; Slater, Worley et al. 
2010).  
 
However, none of the studies have provided us with any robust objective measures 
of neonatal pain.  Hence, there is a need for a robust pain assessment scale in 
neonates that is easy to use, is easily reproducible and takes into account baby’s 
clinical / neurological condition, use of medication and baby’s gestational age. 
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Hormonal responses to pain have also been measured but these need laboratory 
assessment and cannot be done bedside (Franck and Miaskowski 1997). Previous 
studies have shown foetal stress responses to invasive procedures from at least  23 
weeks gestation (Giannakoulopoulos, Sepulveda et al. 1994). Increased 
concentrations of plasma catecholamines and corticosteroids and beta-endorphin 
levels in the CSF of neonates following painful procedures have been shown in 
several studies, but the techniques to obtain these samples are invasive and painful 
(Anand and Hickey 1987; Marshall 1989). Lagercrantz et al, in a combined group of 
term and preterm neonates, showed that there was a greater increase in the levels 
of catecholamines following routine nursing procedures like changing nappies etc 
than following heel prick procedures (Lagercrantz, Nilsson et al. 1986). 
 
These physiological responses and behavioural scores may not reliably reflect the 
underlying degree of pain in a clinically unstable baby who is intubated and is on 
sedatives and paralysing agents. Even though these studies have shown 
behavioural, physiological and biochemical responses to pain, whether or not 
premature neonates process pain at cortical level remained unanswered. As we 
know that cortex is important in pain perception, it is possible that the above 
physiological and behavioural responses could be just reflex responses mediated at 
the lower levels and that premature babies do not perceive any noxious stimulus as 
being painful. Thus, these responses could be measures of nociception rather than 
perception of pain (Slater, Fitzgerald et al. 2007). Studies have shown that spinally 
mediated reflex limb withdrawal from a noxious stimulus is greater in magnitude and 
duration in the youngest infants and decreases with age, in contrast to the cortical 
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responses (Fitzgerald, Shaw et al. 1988; Andrews and Fitzgerald 1994; Andrews and 
Fitzgerald 1999).  
 
1.1.7 TREATMENT OF PAIN IN NEONATES 
 
Both pharmacological (such as morphine, midazolam etc.) and non-pharmacological 
(oral sucrose, pacifiers, developmental care etc) means of pain control are currently 
in use in neonatal units. Even though pain relief is provided after surgery, daily 
routine procedures are still being done without any form of pain control measures 
being taken into consideration (Franck 1987; Tohill and McMorrow 1990; Bauchner, 
May et al. 1992; McLaughlin, Hull et al. 1993; Fernandez and Rees 1994; Johnston, 
Collinge et al. 1997).  There does not seem to be any consensus amongst clinicians 
with regards to the best means of managing pain in neonates.  Anxiety still exists 
with regard to the use of drugs like opiates in neonates, arising mainly from fear 
about their side-effects, and uncertainty about long-term effects on the neuro-
developmental outcomes.  More recently, attention is being paid to the individualised 
developmental care programs (NIDCAP) to reduce the risk of complications such as 
IVH in this vulnerable group of patients with unstable physiological conditions (Als, 
Duffy et al. 1996; Symington and Pinelli 2000). 
 
1.2 HYPOTHESIS 
 
We hypothesised that sweat rate, skin blood flow and cerebral evoked potentials are 
objective correlates of procedural pain in neonates.  
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1.3 AIMS AND OBJECTIVES 
 
1.3.1 PRIMARY OBJECTIVES 
 
 (1) To systematically investigate the relevance of three physiological observations to 
procedural pain (heel prick) in neonates:    
                                (a) Sweat rate. 
                                (b) Skin blood flow. 
                                (c) Sympathetic Skin Response. 
 
(2) To record warm evoked potentials to assess temperature and pain pathway 
maturation in neonates. 
 
1.3.2 SECONDARY OBJECTIVES 
 
(3) To investigate whether behavioural measures of pain (using PIPP) correlate with 
the results from above objective measures of pain. 
 
(4) To investigate whether there are any effects of prematurity and maturation on the 
physiological or evoked potential data. 
 
(5) To investigate whether drug and non-drug pain relief treatments given as part of 
routine clinical care have any effect on the above results. 
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The ability to monitor pain and the effects of its treatment objectively will advance 
pain assessment procedures in neonatal units and enable new, safer drug and non- 
drug treatments to be investigated in neonates with confidence. 
 
1.4 INCLUSION AND EXCLUSION CRITERIA 
 
1.4.1 INCLUSION CRITERIA 
- All babies born at 24-44 weeks postmenstrual age admitted to the Winnicott Baby 
Unit at St Mary's Hospital, London. 
- Who had a parent / guardian who were able and capable of giving informed 
consent on their behalf. 
- Were free from any known neurological conditions / abnormalities that may occlude 
or compromise the results of the study i.e. 
 Antenatally or postnatally detected congenital anomalies 
 Intracranial abnormalities detected on antenatal scans  
 Intraventricular haemorrhage of any grade 
 Babies with neonatal encephalopathy 
 
1.4.2 EXCLUSION CRITERIA 
 
- Babies who did not have a parent / guardian who was able and capable of giving 
informed consent on their behalf. 
- Babies who had any known neurological conditions / abnormalities that may 
occlude or compromise the results of the study (as elaborated in inclusion criteria). 
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CHAPTER 2 
 
USE OF SWEAT RATE FOR THE ASSESSMENT OF PAIN IN 
NEONATES 
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2.1 INTRODUCTION 
 
2.1.1 SWEAT RATE IN NEONATAL PAIN RESEARCH 
 
Palmar sweat rate has been investigated as a marker of stress and pain in neonates 
by several previous investigators. Sweating from the palm of the hand and sole of 
the foot is a measure of the electro dermal activity and reflects the emotional state of 
a person, also called ‘Emotional Sweating or Mental Sweating’. Sweating from these 
areas is independent of factors such as ambient room temperature and humidity, 
unlike rest of the body (thermal sweating), and has been shown to increase at times 
of stress, fear, anxiety etc.  
 
Palmar and plantar sweat glands are well developed from about 28 weeks with their 
innervation by the sympathetic nervous system being present much earlier, at about 
18 weeks gestational age (Nessmann and Baverel 1972).  Whenever the 
sympathetic nervous system is activated, as in a stress response, there is a release 
of acetylcholine from the post-ganglionic nerve terminals which activates muscarinic 
receptors. This causes secretion from the palmar and the plantar sweat glands, and 
hence sweating. In both thermal and emotional sweating, the cholinergic fibres of 
sympathetic nervous system are involved. However, emotional sweating is controlled 
by a higher centre in premotor cortex (anterior cingulate cortex ) and the thermal 
sweating is controlled by the hypothalamus (Tranel and Damasio 1994). 
 
Palmar Sweat Index was used in early paediatric research but the results were 
highly variable and difficult to interpret (Gedaly-Duff 1989). Initial studies in babies 
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failed to show the presence of emotional sweating or its correlation with the state of 
arousal and it was thought that palmar sweating did not occur until 2 months of age 
(Verbov and Baxter 1974).  However, subsequent studies have demonstrated a clear 
relationship between the palmar sweating (as measured with evaporimeter) and the 
state of arousal in babies ≥ 36-37 weeks gestation and also showed that by third 
week of life the levels in vigorously crying babies were comparable to anxious adults 
(Harpin and Rutter 1982a; Harpin and Rutter 1982b).  These studies have also 
shown that the thermal sweating response is dramatically increased in postnatal life, 
and almost all babies sweat in response to high ambient temperature by the age of 2 
weeks (Harpin and Rutter 1982a; Harpin and Rutter 1982b).  
 
In our study we have measured the palmar sweat levels in response to the heel prick 
procedure, in order to investigate its relationship to procedural pain.  
 
2.2 METHODS 
 
2.2.1 SUBJECTS 
 
A total of 18 recordings for the sweat test were made on 12 babies whose 
gestational ages varied from 28+5 to 39 weeks, and who were between 1 and 43 
days old (Appendix A - Table 2.1, page 97). 
 
2.2.2 SWEAT RATE TESTING 
 
The palmar sweat levels were measured using an Evaporimeter EP1 (Servomed,  
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Sweden). This device works on the principle of measurement of water vapour 
pressure gradient close to the skin surface. This gradient is directly proportional to 
the rate of evaporation of water from the skin (trans-epidermal water Loss). 
 
 
Image 2.1: Evaporimeter with the probe (highlighted in the red circle) 
 
Babies were studied in a cot or in an unhumidified incubator. The clinically required 
heel prick was performed by the clinician on the unit using a standard Unistix 3 
lancet. The readings were taken from the palm of the hands. The evaporimeter 
probe was gently placed on the skin surface until a steady reading of water loss was 
obtained. This water loss was measured in g/m2 per hour. A baseline reading was 
obtained before the heel prick procedure till the reading on the evaporimeter 
stabilised. The monitoring was continued during the heel prick procedure and after 
the heel prick procedure till stable readings were obtained.  
 
During this period of monitoring, babies’ heart rate, respiratory rate and the oxygen 
saturations were also noted (Appendix A - Table 2.2, page 97). Where possible, a 
video recording of the babies was made for a later behavioural analysis. A note was 
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also made of any pain relief given to the babies. None of the babies studied received 
any other medication (other than oral sucrose) including inotropes or opiates. 
 
The protocol was approved by the ethics committee and written consent was taken 
from parents before the study. 
 
Details of babies’ gestational age, postnatal age, birth weight, current weight and 
other clinical details were obtained from the Badger system (Electronic clinical 
(patient) record system). Gestational age was determined from antenatal ultrasound 
scans or from the maternal report of the last menstrual period (as obtained from the 
Badger). 
 
2.2.3 ANALYSIS OF RESULTS 
 
Results were analysed and graphs were created using GraphPad Prism version 3.02 
for Windows (GraphPad Software, SanDiego, California USA). 
 
2.2.4 RESULTS 
 
The babies were divided into different groups and the analysis was done as 
described below. We could not study the effect of analgesics used as all babies 
received oral sucrose (as a part of unit protocol) before the heel prick procedures. 
 
Babies who were born at different gestational ages (grouped as 24-29+6 weeks, 30-
33+6 weeks, 34-36+6 weeks and ≥ 37 weeks) were further subdivided into various 
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postnatal ages (grouped as 1st week, 2nd week, 3rd week and >3 weeks) (Appendix A 
- Table 2.2, page 97). The sweat levels were measured as described above. 
However, because the numbers in each of the subgroups above were small, we 
could not perform any statistical tests to analyse any differences amongst them 
(Details of the subgroup analysis are presented in Appendix B – page 104).  
 
Hence without dividing them into subgroups based on their gestational and postnatal 
ages, we performed a linear regression analysis of the pre (baseline) and post heel 
prick sweat levels of all babies based on their corrected gestational ages at the time 
of testing. The corrected ages of babies ranged from 29 weeks to 39 weeks. Using 
the Spearman test, we looked for the correlation between the pre (baseline) / post 
heel prick sweat levels and the corrected gestational ages of the babies. We then 
used the Mann-Whitney test to compare the pre (baseline) sweat levels with the post 
heel prick sweat levels.  
 
As seen in figure 2.5, the mean baseline (pre or resting) sweat levels clearly 
increased with gestational age (r = 0.5438, p = 0.0197). The post heel prick sweat 
levels also increased with the gestational age of babies r = 0.6794, p = 0.0019).  
 
When we compared the mean pre heel prick levels with the mean post heel prick 
levels at all ages (figure 2.6), there was no significant change  (p = 0.4964). 
 
We then used the ratio of post / pre heel prick values to analyse the results. Firstly a 
simple linear regression relating this ratio to gestational age gave results which are 
not statistically significant (p = 0.565). Secondly, a multiple regression analysis was 
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performed relating the ratio to gestational age, the pre-heel prick value, and the age 
of the baby. This shows a statistically significant relationship between the post / pre 
heel prick ratio and gestational age (p = 0.0366), after adjusting for pre-heel prick 
value (p = 0.0449) and the age (p = 0.0858). No other factors were statistically 
significant in this exploratory multiple regression. Hence, there is evidence that the 
change in sweat measurements (post as a ratio of pre) are related to gestational age 
but that the pre-heel prick results and perhaps the age of the baby are confounding 
factors in this relationship. 
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Figure 2.5: Linear regression analysis comparing pre and post heel prick 
sweat levels with corrected gestational ages (CGA) 
 
 
40 
 
Comparison of pre and post heel prick sweat levels
Pr
e 
Po
st
 
0
10
20
30
40
Post
Pre
S
w
e
a
t 
le
v
e
ls
 i
n
 g
/m
2
 p
e
r 
h
o
u
r
Comparison of pre and post heel prick sweat levels
Pr
e 
Po
st
 
0
50
100
150
Pre
Post
S
w
e
a
t 
le
v
e
ls
 i
n
 g
/m
2
 p
e
r 
h
o
u
r
 
 
Figure 2.6: Comparing the pre heel prick with post heel prick sweat levels at all 
ages (Top – Bar chart showing mean ± SEM, Bottom – Before & After plot 
showing individual mean readings) 
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In order to find out if there were any differences in the mean baseline and post heel 
prick sweat levels in babies with different birth weights, the babies were divided into  
three major groups based on their birth weight and the mean pre and post heel prick 
results were analysed which did not show any statistical difference (Details of this 
sub group analysis presented in Appendix B – page 104). 
 
2.3 DISCUSSION 
 
Palmar sweat response has been investigated as a marker of pain in neonates 
previously. It seems unlikely that the sweating from palmar or plantar skin in 
neonates just reflects the trans-epidermal water loss, since the epidermis in these 
areas is thicker than elsewhere and the rates of water loss from these areas exceeds 
other sites in the absence of thermal sweating (Hammarl-nd, Nilsson et al. 1977; 
Rutter and Hull 1979; Harpin and Rutter 1982a; Harpin and Rutter 1982b).  
 
We performed a linear regression analysis of the sweat results based on corrected 
ages (29-39 weeks). The mean baseline (pre or resting) sweat levels clearly 
increased with gestational age (p = 0.0197). The post heel prick sweat levels also 
increased with the gestational age of babies (p = 0.0019). When comparing the 
mean pre heel prick levels with the mean post heel prick levels at all ages, there was 
no significant change  (p = 0.4964). A simple linear regression relating post / pre heel 
prick sweat ratio to gestational age gave results which are not statistically significant 
(p = 0.565). A multiple regression analysis relating this ratio to gestational age, the 
pre-heel prick value, and the age of the baby showed a statistically significant 
relationship between the post / pre heel prick ratio and gestational age (p = 0.0366), 
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after adjusting for pre-heel prick value (p = 0.0449) and the age (p = 0.0858). No 
other factors were statistically significant in this exploratory multiple regression. So 
our study has shown some evidence that the change in sweat measurements (post 
as a ratio of pre) are related to gestational age but that the pre-test results and 
perhaps the age of the baby are confounding factors in this relationship. 
 
We also performed sub group analysis of sweat levels based on babies’ gestational 
ages after dividing them into four major groups as described in the earlier sections of 
the thesis. In our study, babies ≥ 36-37 weeks show a definite palmar emotional 
sweating response (mean baseline and post heel prick levels higher than at earlier 
gestations) which varies greatly with their state of arousal – being lowest when 
asleep and highest when crying. Our study did not show a striking increase in sweat 
levels post heel prick as in the previous studies (Harpin and Rutter 1982a; Harpin 
and Rutter 1982b).  However, we could not perform any statistical tests in this group 
because of low numbers (n = 4 in week 1 and 0 in week 2, 3 and 4). Babies born at 
34-36+6 weeks showed only slight but definite increases in the palmar sweat loss in 
the first and second week of life. We could not perform any statistical tests in this 
group either because of low numbers (n = 3 in week 1, n = 1 in week 2, n = 0 in week 
3 and n = 0 in week 4). Babies born at 30-33+6 weeks also showed minimal 
variations in the palmar water loss till the third week of life with the variation slightly 
more pronounced after 3 weeks of life (p = 0.7). Babies born at 24-29+6 weeks 
showed little variation in the palmar sweat loss in the first 3 weeks of life and the 
results were not statistically significant (p = 1.0). 
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Subgroup analysis of sweat levels based on babies’ birth weights did not show any 
difference in the three groups (p = 0.4).  
 
The major limitation of our study was a very small sample size. Dividing babies into 
various gestational age groups and then further into different postnatal age groups 
further reduced the numbers in each group thereby limiting the ability to perform 
statistical analysis of the results. This problem was however overcome by performing 
a linear regression analysis of results based on corrected gestational ages. Whether 
the administration of sucrose to the babies could have altered our results would have 
been possible to ascertain by doing a subgroup analysis comparing babies who 
received sucrose with babies who did not receive any sucrose. This was not possible 
in our study since all babies received oral sucrose prior to heel prick as a part of unit 
protocol. 
 
Our study agrees with the previous studies (Harpin and Rutter 1982a; Harpin and 
Rutter 1982b) in that the palmar sweat response reflects the emotional state and 
correlates with the state of arousal, but this response may not be very specific to 
pain.  As palmar/ plantar sweat loss reflects the sympathetic response to stress, it 
may not be a very reliable tool in assessing pain in neonates.  However, since the 
sample size was small in our study, further studies need to be done with a larger 
sample size in order to be able to draw conclusions with confidence. 
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CHAPTER 3 
 
BEHAVIOURAL ANALYSIS OF PAIN USING PREMATURE INFANT 
PAIN PROFILE AND ITS CORRELATION WITH PALMAR SWEAT 
RATE 
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3.1 INTRODUCTION 
 
3.1.1 BEHAVIOURAL ANALYSIS OF NEONATAL PAIN 
 
Over the years, behavioural responses to pain in neonates have been extensively 
studied. These responses to pain include crying, movements of limbs, facial 
expressions and changes in sleeping/ waking patterns. Based on various 
physiological and behavioural indicators, more than 40 different pain assessment 
scores are in use worldwide (Ranger, Johnston et al. 2007), many using similar 
criteria although no 'gold standard' exists. The most commonly used pain 
assessment tools such as the PIPP (Premature Infant Pain Profile),  NIPS (Neonatal 
Infant Pain Scale), CRIES (Crying, Requires Increased FiO2, Increased vital signs, 
Expression & Sleeplessness)  are intended primarily for evaluating pain experience 
during acute procedures such as heel sticks and are often difficult to score 
accurately in the clinical setting. Scores may be invalidated by the babies’ 
neurological state and drugs like sedatives and paralysing agents. Some scales are 
adjusted to take into account that behavioural and physiological responses of infants 
differ depending on gestational age. Also, not all scales in use are appropriate for 
both term and preterm babies. There are fewer scales for evaluating ongoing pain, 
the most commonly cited being the French EDIN (Échelle Douleur Inconfort 
Nouveau-Né, neonatal pain and discomfort scale) (Debillon, Zupan et al. 2001) and 
N-PASS (Neonatal Pain, Agitation and Sedation Scale) (Hummel, Puchalski et al. 
2008).  Hence, there is a need for a pain assessment method that is easy to use, 
gives quick results, and is valid and reliable and is more objective. 
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3.1.2 PREMATURE INFANT PAIN PROFILE 
 
The reason we selected the Premature Infant Pain Profile (PIPP) for our study is that 
PIPP is one of the most frequently used scores and has been validated for use in 
premature neonates (Stevens, Johnston et al. 1996). It was developed at the 
Universities of Toronto and McGill in Canada. It is a 7 indicator composite pain 
measure (Appendix A – Table 3.1, page 100) that includes: 
(1) Gestational age  
(2) Behavioural state before painful stimulus  
(3) Change in heart rate during painful stimulus  
(4) Change in oxygen saturation during painful stimulus  
(5) Brow bulge during painful stimulus  
(6) Eye squeeze during painful stimulus  
(7) Nasolabial furrow during painful stimulus  
 
Babies’ gestational age is scored before the assessment. Baby is then observed for 
15 seconds prior to the potentially painful event to score the behavioural state. 
Babies’ baseline heart rate and oxygen saturation are recorded. The baby is then 
observed for 30 seconds immediately following the painful event to score the facial 
and physiologic changes during this time. Premature infant pain profile is calculated 
as the sum of points for all 7 indicators. The minimum score is 0 and the maximum 
score 21; higher the score, greater the pain behaviour. 
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In our study we performed the behavioural analysis in response to a clinically 
required heel lance procedure in babies using PIPP score and compared the scores 
with the findings of the sweat analysis to see if there is any correlation.  
 
3.2 METHODS 
 
3.2.1 SUBJECTS 
 
We performed behavioural analysis using the Premature Infant Pain Profile (PIPP) in 
response to the clinically required heel lance procedure.  A total of 16 video 
recordings were done in 11 babies. However PIPP scoring could not be done in case 
of 9 recordings (6 babies) due to poor quality video (1 recording), no monitoring of 
heart rate and saturations as babies stable and in cots (6 recordings) and monitoring 
with Doppler assessments (2 recordings). Hence, we were able to perform PIPP 
analysis only in case of 7 recordings (6 babies)  whose corrected gestational ages 
varied from 29+3 to 38+4 weeks, and who were between 1 and 43 days old 
(Appendix A - Table 3.2, page 101). 
 
3.2.2 BEHAVIOURAL ANALYSIS 
 
Babies were studied in a cot or in an unhumidified incubator. Sweat levels were 
obtained in response to heel prick procedure as above. Where possible, a video 
recording of the babies was made for a later behavioural analysis. During this period 
of monitoring, babies’ heart rate, respiratory rate and the oxygen saturations were 
also noted. PIPP scoring was later on done by two neonatologists independently 
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(score 1 and 2) on the Winnicott Baby Unit who were not present at the time of the 
procedure/ recordings to avoid any possibility of bias. A mean of these scores was 
calculated for each baby separately and then compared with the changes in the 
sweat levels. For the purposes of this study, even the mean scores in decimals have 
been used.  We also compared the scores given by the two neonatologists with each 
other to look for any inter-observer bias. 
 
The protocol was approved by the ethics committee and written consent was taken 
from parents before the study. 
 
Details of babies’ gestational age, postnatal age, birth weight, current weight and 
other clinical details were obtained from the Badger system (Electronic clinical record 
system). Gestational age was determined from antenatal ultrasound scans or from 
the maternal report of the last menstrual period (as obtained from the Badger). 
 
3.2.3 RESULTS 
 
We performed linear regression analysis to compare pre (baseline) and post heel 
prick sweat levels with the mean PIPP scores (Figure 3.1). Using Spearman test (n = 
7), this showed a negative correlation between mean PIPP scores and pre heel prick 
sweat levels (r = -0.50, p = 0.26) and post heel prick levels (r = -0.82, p = 0.03*). 
Table 3.2 (Appendix A, page 101) illustrates the correlation between the PIPP scores 
and the sweat levels. As seen, in case of recording 1, 2, and 3, the mean PIPP score 
was low which correlated very well with the mean sweat levels post heel prick that 
did not show any significant increase.  However, in case of recording 4, 5, 6 and 7, 
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the mean PIPP scores were very low but there was a definite increase in the mean 
sweat levels post heel prick as compared to the baseline levels. 
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Figure 3.1: Linear regression analysis comparing mean pre and post heel prick 
sweat levels with mean PIPP scores  
 
Interestingly, when we compared the two PIPP scores with each other (Table 3.2 -
Appendix A, page 101), although they agreed with each other in most cases 
(recordings 1, 3, 4 and 6), there were marked differences in some (recordings 2, 5 
and 7). As seen in figure 3.2, we compared the scores using Mann Whitney test (n = 
7) that failed to show any significant correlation between the scores (p = 0.27). 
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Figure 3.2: Comparison of PIPP scores given by the two observers (Before & 
After plot) 
 
3.3 DISCUSSION 
 
Amongst the behavioural responses, facial expression has been shown to be the 
most consistent and specific pain response (Grunau and Craig 1987; Grunau, 
Oberlander et al. 1998). However, there is a poor correlation with behavioural and 
physiological indicators of pain (Johnston, Stevens et al. 1995). This is supported by 
attenuation of the behavioural but not the physiological responses to venepuncture 
by oral glucose intervention suggesting that the latter may be related to stress rather 
than pain (Bauer, Ketteler et al. 2004). It has been suggested that it is possible that 
the nociceptive pathways originating from the spinal cord and conveying information 
to the thalamus and somatosensory cortex more reliably activate the brainstem 
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nuclei responsible for facial expression than the cardiovascular and respiratory 
control centres (Bauer, Ketteler et al. 2004). In their study, Slater et al showed that 
the infants demonstrated a clear cortical response following a heel prick lance, but 
did not show any changes in facial expression (Slater, Fitzgerald et al. 2007). The 
authors have postulated that the absence of facial activity may be due to immature 
motor circuitry failing to produce synchronised and coordinated muscle contraction or 
may indicate true absence of emotion. This means that if an infant does not 
demonstrate a change in facial expression, it cannot be assumed that the stimulus 
has not reached cortex  (Slater, Fitzgerald et al. 2007). 
 
In our study, we could not demonstrate a clear relationship between the behavioural 
responses (as assessed using PIPP score) and an objective marker of stress 
(palmar sweat levels). Linear regression analysis (n = 7), showed a negative 
correlation between mean PIPP scores and pre heel prick sweat levels (p = 0.26) 
and post heel prick levels (p = 0.03*). Comparison of the PIPP scores with each 
other (n = 7) failed to show any significant correlation between the scores (p = 0.27). 
 
The major limitation of our study again was a small sample size. In addition, some of 
the videos could not be assessed due to poor quality. This also highlights the 
technical difficulties in using a scoring system to assess pain in neonates in a clinical 
setting. One of the major challenges was trying to score facial responses in babies 
who were in an incubator, with various tubing attached and limited access / visibility.   
Besides, inter-observer variability was also noted in our PIPP scores, questioning 
their reliability. Whether the administration of sucrose to the babies could have 
altered our results would have been possible to ascertain by doing a subgroup 
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analysis comparing babies who received sucrose with babies who did not receive 
any sucrose. This was not possible in our study since all babies received oral 
sucrose prior to heel prick as a part of unit protocol. 
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CHAPTER 4 
 
USE OF SYMPATHETIC SKIN RESPONSE FOR THE ASSESSMENT 
OF PAIN IN NEONATES 
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4.1 INTRODUCTION 
 
4.1.1 SYMPATHETIC SKIN RESPONSE IN NEONATAL PAIN RESEARCH 
 
Sympathetic Skin Response (SSR) is a way of assessing electrodermal activity, and 
reflects sympathetic cholinergic function which leads to a change in the skin 
resistance to electrical conduction. This principle is well used in adults in 
psychological research, and forms one component of ‘Lie Detector’ tests (Christie 
1981; Bauer 1998).  
 
The SSR can be recorded using the EMG machine.  SSR is generally recorded with 
the active electrodes placed on the palm or sole.  It has also been recorded from the 
forehead, axilla (Baba, Watahiki et al. 1988) and the genitalia (Ertekin, Ertekin et al. 
1987).  The stimulus can be an inspiratory gasp, a cough, a loud noise, an electrical 
stimulus, a skin stroke etc.  SSR response curves normally consist of a negative and 
a positive phase (Baba, Watahiki et al. 1988; Arunodaya and Taly 1995).  The 
negative or upward deflection (low amplitude) is followed by a positive or downward 
deflection (high amplitude).  The SSR potential can, however, vary with ambient and 
baby’s temperature, emotional state, skin potential level, arousing stimuli (surprise 
effect), habituation of response with repeated stimulations, and inter- and intra- 
individual variability (Vetrugno, Liguori et al. 2003).  The source of the negative 
component of SSR is sweat gland itself, and depends directly on neuronal activation 
(Takagi and Nakayama 1959; Shaver, Brusilow et al. 1962).  However, the source of 
the positive component is not fully established (Yokota, Takahashi et al. 1959; 
Shaver, Brusilow et al. 1962; Vetrugno, Liguori et al. 2003).  
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SSR has been studied in adults with excessive and defective sweating, peripheral 
arterial diseases (Argyriou, Tsolakis et al. 2006), carpal tunnel syndrome (Kiylioglu, 
Akyol et al. 2005; Bayrak, Tilki et al. 2007), COPD (Bir, Ozkurt et al. 2005), reflex 
sympathetic dystrophy (Bolel, Hizmetli et al. 2006), depression (Boettger, Greiner et 
al. 2010), post auricular region in Meniere’s disease (Yildiz, Koybasi et al. 2007) and 
Parkinson’s disease (Schestatsky, Ehlers et al. 2006).  To our knowledge, SSR has 
never been studied in neonates. 
 
SSR is simple, fast and readily obtainable on most electrophysiological equipment. 
However it has several limitations. The response readily habituates, may be difficult 
to reproduce consistently, there may be incomplete reactions to inappropriate stimuli 
and may be unpredictably absent even in normal subjects (Vetrugno, Liguori et al. 
2003).  
 
 
 
 
Figure 4: Typical SSR recordings taken from the right palm (upper trace) and 
left palm (lower trace) following stimulus of (a) left median nerve and (b) 
cervical cord (Chroni et al. 2006) 
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Sweating from the palmar and plantar sweat glands as measured by skin 
conductance activity (using different equipment from SSR) has been studied by 
several investigators.  Skin conductance is measured in terms of a baseline activity 
and frequency and amplitude of the waves.  A study by Storm et al (2000) has 
concluded that this spontaneous skin conductance reflects the stress response to 
heel stick in premature infants from at least 29 weeks gestation, and the behavioural 
state mirrored these changes (Storm 2000).  More recent studies have shown SCRs 
to occur in infants from 25 weeks gestational age (Luis Pereira-da-Silva I M 2009; 
Slater, Cantarella et al. 2009). 
 
In our study, we recorded the sympathetic skin response in a baby using a standard 
EMG machine in response to a clinically required heel prick. 
 
4.2 METHODS 
 
4.2.1 SUBJECTS 
 
A total of 1 recording for the sympathetic skin response was made on 1 baby whose 
gestational age at birth was 31+2 weeks, with a corrected gestational age of 34+4 
weeks and who was 23 days old. Baby’s birth weight was 923 grams and the weight 
at the time of assessment was 1090 grams. 
 
4.2.2 SYMPATHETIC SKIN RESPONSE TESTING 
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We measured the SSR using a Dantec Keypoint EMG machine using surface ECG 
electrodes with appropriate amplifier filter frequencies.  
 
Baby was studied in an unhumidified closed incubator. The heel prick was performed 
using a standard Unistix 3 lancet.  
 
Before the heel prick procedure was done, standard surface ECG leads were placed, 
one on the right palm, one on the dorsum of right hand and one on the right thigh.  A 
baseline recording of the number of SSR waves per minute was done prior to the 
heel prick. A subsequent recording of the number of waves per minute was made for 
two successive minutes after the heel prick. 
 
During this period of monitoring, baby’s heart rate, respiratory rate and the oxygen 
saturations were also noted. A note was also made of any pain relief given to the 
baby.  As per the unit protocol, this subject received oral sucrose prior to the heel 
prick procedure, and did not receive any other medication including inotropes or 
opiates. 
 
The protocol was approved by the ethics committee and written consent was taken 
from parents before the study. 
 
Details of babies’ gestational age, postnatal age, birth weight, current weight and 
other clinical details were obtained from the Badger system (Electronic clinical record 
system). Gestational age was determined from antenatal ultrasound scans or from 
the maternal report of the last menstrual period (as obtained from the Badger). 
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4.2.3 RESULTS 
 
Our results did not show any increase in the number of SSR waves per minute in 
response to the clinically required heel prick procedure. The baseline SSR rate was 
 5 SSRs / minute and the rates during the first and second minutes post heel prick 
were 2 SSRs / minute and 4 SSRs / minute respectively.  
 
4.3 DISCUSSION 
 
SSR has already been proposed as an indicator of sudomotor function and as an 
index of body’ reaction to emotion and attention in adults (Shahani, Halperin et al. 
1984; Knezevic and Bajada 1985). The feasibility of using SSR as an indicator of 
body’s response to stress or pain in neonates remains to be established. 
 
We were able to record SSR in only one baby and that was the major limiting factor 
in our study. Hence would need a much larger sample in order to interpret the results 
with confidence.  On the basis of our finding and previous reports, we considered 
that study of more babies with SSR was unlikely to show correlations with pain 
scores.   
 
 
 
 
 
 
59 
 
CHAPTER 5 
 
USE OF SKIN BLOOD FLOW FOR THE ASSESSMENT OF PAIN IN 
NEONATES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
5.1 INTRODUCTION 
 
5.1.1 DOPPLER SKIN BLOOD FLOW IN NEONATAL PAIN RESEARCH 
 
Skin blood flow changes around a painful stimulus (like heel prick) is a function of 
nociceptive fibres; whereas changes in skin blood flow in other parts of body in 
response to heel prick or any painful stimulus reflects the sympathetic response to 
pain. These changes in skin blood flow in response to various stimuli have been 
studied previously by several investigators. 
 
McCulloch et al (1995) measured blood flow changes in 15 infants using laser 
Doppler technique with a probe placed on the lateral abdominal wall. They found that 
skin blood flow increased significantly (27-134%) during lancet puncture of the heel, 
physical handling, standard suctioning and chest physiotherapy, and there were no 
changes during closed suctioning. Skin blood flow reduced significantly (35% by 20 
minutes) after intravenous morphine (McCulloch, Ji et al. 1995). They postulated that 
substance P could be the link between pain and increased skin blood flow. 
Substance P is a neurotransmitter known to be associated with nociception and 
vasodilatation (Piercey, Schroeder et al. 1981; Charnay, Paulin et al. 1983; 
Walmsley and Wiles 1990; Spigelman and Puil 1991). Studies have shown that both 
the release of substance P from primary sensory afferent nerve terminals and 
substance P induced vasodilatation are inhibited by opioid agonists in a naloxone-
reversible manner (Jessell and Iversen 1977; Lembeck and Donnerer 1985; Khalil 
and Helme 1991).  
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A study done by Kunzek et al (1997) concluded that skin perfusion as measured 
using doppler fluximetry was unreliable in quantifying the sympathetic response to a 
noxious stimulus in preterm infants (Kunzek, Quinn et al. 1997). They studied skin 
blood flow changes in the heel contra lateral to the heel prick site. They looked at 16 
preterm infants undergoing standard heel prick and found that although there was a 
significant reduction in skin blood flow following heel prick, this was variable and 
dependent on basal skin blood flow and there were also loss of data due to 
movement artefact. Kunzek and colleagues showed that preterm newborns react to 
noxious stimulus by reducing their skin blood flow as described in adults but the 
degree of reduction appeared much lower than adults (median % reduction 11% vs. 
25-40% in adults). They concluded that these differences could be attributed to 
differences in anatomy between babies and adults i.e. capillary vasculature may be 
poorly developed in babies; incompletely developed arterio-venous anastomosis in 
the sole of foot (responsible for 90% of laser Doppler signal from the area of skin 
investigated) (Sherman 1963); and the degree of underlying basal vasoconstrictor 
tone.  
 
In our study we used a laser Doppler technique to look for blood flow changes 
around the heel prick site and in the contra lateral foot in response to a clinically 
required heel lance. 
 
5.2 METHODS 
 
5.2.1 SUBJECTS 
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A total of 19 recordings for the skin blood flow in the peri-heel prick site (ipsi-lateral) 
were made on 15 babies whose gestational ages varied from 29+1 to 37 weeks, and 
who were between 2 and 26 days old (Appendix A - Table 5.1, page 102).  
 
A total of 27 recordings for the skin blood flow in the foot opposite to the heel prick 
(contra-lateral) were made on 13 babies whose gestational ages varied from 24+4 to 
41+4 weeks, and who were between 2 and 77 days old (Appendix A - Table 5.2, 
page 102). 
 
5.2.2 SKIN BLOOD FLOW TESTING 
 
We measured microvascular perfusion using PeriFlux 4001 Master multichannel 
laser Doppler system (Perimed, Stockholm, Sweden) which works on the principle of 
Doppler shift. The range for Doppler shift measurements for the instruments is 20 Hz 
to 20 kHz.  
 
 
Image 5.1: Laser Doppler system (probe highlighted in red circle) 
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Babies were studied in an open cot or an unhumidified incubator. The heel prick was 
performed using a standard lancet Unistix 3 lancet. 
 
The laser doppler probe (Standard 408 Probe) was placed in a plastic probe holder 
(PF104), and the holder was fixed using tensoplast adhesive plaster without 
pressure to the skin around the heel prick site in case of peri-heel prick recordings 
and in the middle of the heel of the opposite foot in case of contra lateral recordings. 
In case of readings taken around the heel prick site (peri-heel prick), the doppler 
probe was gently placed on the heel for a few minutes prior to the heel prick stimulus 
till a stable baseline reading was obtained. The probe was re-placed at the same site 
after the heel prick to look for the changes in blood flow.  
 
In case of readings taken from the contra lateral limb, the probe was left on the 
contra lateral foot continuously throughout the procedure.  
 
The mean skin blood flow in PU (red trace – measured readings) was recorded 
during the following observation periods:  
1. Pre-heel prick (in both peri- and contra-lateral readings). 
2. Post heel prick (during squeezing) at 1 min/ 3 min/ 5 min (only in case of 
contra-lateral limb recordings). 
3. Post end of sampling/ squeezing at 1 min/ 3 min/ 5 min (both peri- and contra- 
lateral readings) 
 
The data was recorded continuously as a trace on a laptop screen using the Perisoft 
software (Perisoft for windows, version 2.50). The mean readings of skin blood flow 
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were obtained using the same software. Spikes associated with limb movements 
were identified and rejected as artefacts. 
 
 
 
Figure 5.1a: Sample trace from a baby illustrating the baseline skin blood flow 
as measured in PU (red trace representing the output / measured readings) 
X - axis: time in minutes and seconds, y - axis: skin blood flow  
 
 
 
 
Figure 5.1b: Sample trace from the same baby illustrating the increase in skin 
blood flow post heel prick (red trace representing the output and measured 
readings)  
X - axis: time in minutes and seconds, y - axis: skin blood flow  
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The protocol was approved by the ethics committee and written consent was taken 
from parents before the study. 
 
During this period of monitoring, babies’ heart rate, respiratory rate and the oxygen 
saturations were also noted (Appendix A - Table 5.3, page 103). A note was also 
made of any pain relief given to the babies. None of the babies studied received any 
other medication (other than oral sucrose) including inotropes or opiates. 
 
Details of babies’ gestational age, postnatal age, birth weight, current weight and 
other clinical details were obtained from the Badger system (Electronic clinical record 
system). Gestational age was determined from antenatal ultrasound scans or from 
the maternal report of the last menstrual period (as obtained from the Badger). 
 
5.2.3 ANALYSIS OF RESULTS 
 
Results were analysed and graphs were created using GraphPad Prism version 3.02 
for Windows (GraphPad Software, SanDiego, California USA). 
 
5.2.4 RESULTS 
 
Mean skin blood flow changes pre-heel prick (baseline) and at various intervals post 
heel prick were calculated by taking into account the results obtained by using the 
Perisoft software (Perisoft for windows, version 2.50). Our results have shown a wide 
range of changes in the blood flow both around the heel prick site and in the contra 
lateral foot after the procedure. Even though the mean skin blood flow in the babies 
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post heel prick increased, the changes were varied with some babies showing a 
decrease and some an increase post heel prick (Figure 5.2, 5.3 and Appendix A - 
Table 5.4, 5.5, page 103-104). There was also loss of some data due to movement 
artefact. We could not study the effect of analgesics used as all babies received oral 
sucrose (as a part of unit protocol) before the heel prick procedures. 
 
Table 5.4 (Appendix A, page 103) and Figure 5.2 illustrate the mean blood flow 
changes around the heel prick site. We used Mann Whitney test (n = 22) to compare 
the baseline skin blood flow around the heel prick site with changes at various 
intervals post heel prick. The analysis did not reveal the results to be statistically 
significant i.e.  
Baseline vs. Post end sampling 1 min (p = 0.75),  
Baseline vs. Post end sampling 3 min (p = 0.13), 
Baseline vs. Post end sampling 5 min (p = 0.87). 
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Figure 5.2: Mean blood flow changes in the peri-heel prick (ipsi-lateral foot) 
recordings following a heel prick (Bar chart showing mean ± SEM) 
 
Table 5.5 (Appendix A, page 103) and Figure 5.3 illustrate the mean blood flow 
changes in the contra-lateral limb. We used Mann Whitney test (n = 29) to compare 
the baseline skin blood flow in the contralateral foot with changes at various intervals 
post heel prick. The analysis did not reveal the results to be statistically significant 
except post heel prick at 1 minute i.e.  
Baseline vs. Post Heel Prick 1 min (p = 0.03*), 
Baseline vs. Post Heel Prick 3 min (p = 0.07), 
Baseline vs. Post Heel Prick 5 min (p = 0.640, 
Baseline vs. Post End Sampling 1 min (p = 0.26), 
Baseline vs. Post End Sampling 3 min (p = 0.86), 
Baseline vs. Post End Sampling 5 min (p = 0.93). 
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Figure 5.3: Mean blood flow changes in the contra-lateral foot following a heel 
prick (Bar chart showing mean ± SEM) 
 
We performed a linear regression analysis of the pre (baseline) and post (peak 
levels) heel prick skin blood flow of all babies based on their corrected gestational 
ages at the time of testing.  
 
In the ipsi-lateral (peri-heel prick) group, the corrected ages of babies ranged from 
30 weeks to 38 weeks. Using the Spearman test, we looked for the correlation 
between the pre (baseline) / post (peak) heel prick skin blood flow and the corrected 
gestational ages of the babies. We used the Mann-Whitney test to compare the pre 
(baseline) skin blood flow with the post (peak) heel prick levels to look for any 
changes.  
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As seen in figure 5.4, there does not appear to be any correlation between either the 
pre (baseline) skin blood flow (r -0.526, p 0.816) or the post (peak levels) heel prick 
skin blood flow (r 0.063, p 0.803) with gestational age in the peri-heel prick group. 
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 Figure 5.4: Linear regression analysis comparing pre and post heel prick skin 
blood flow with corrected gestational ages in ipsi-lateral group 
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Figure 5.5 illustrates that there was no significant increase in skin blood flow post 
heel prick (p 0.377). 
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Figure 5.5: Comparing the pre heel prick with post heel prick skin blood flow at 
all ages in ipsi-lateral group (Top – Bar chart showing mean ± SEM, Bottom – 
Before & After plot showing individual mean readings) 
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In the contra-lateral foot group, the corrected ages of babies ranged from 30 weeks 
to 42 weeks.  As seen in figure 5.6, there appears to be a trend for negative 
correlation between the pre (baseline) skin blood flow (r -0.318, p 0.099) and the 
post (peak levels) heel prick skin blood flow (r -0.345, p 0.084) with their gestational 
ages in the contra-lateral foot group. 
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Figure 5.6: Linear regression analysis comparing pre / post heel prick skin 
blood flow with corrected gestational ages in contra-lateral group 
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Figure 5.7  illustrates that there was a significant increase in skin blood flow in the 
contra-lateral limb post heel prick as compared to the pre (baseline) (p ** 0.0016). 
However, this result needs to be interpreted with caution as seen the results could 
be skewed by a few readings (2 values were very high). 
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Figure 5.7: Comparing the pre heel prick with post heel prick skin blood flow at 
all ages in contra-lateral group (Top – Bar chart showing mean ± SEM, Bottom 
– Before & After plot showing individual mean readings) 
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We then used the ratio of post / pre heel prick values to analyse the results with 
linear regressions fitted to test the relationship with gestational age. In neither set of 
measurements was the relationship statistically significant (p = 0.73, ipsilateral data; 
p = 0.67 contralateral data). So, for the Doppler changes, there is no evidence of a 
relationship to gestational age, but perhaps this is confounded by other factors. 
 
5.4 DISCUSSION 
 
Changes in skin blood flow in response to various procedures have been studied in 
neonates by some investigators previously (McCulloch, Ji et al. 1995; Kunzek, Quinn 
et al. 1997). 
 
In our study we used PeriFlux 4001 Master multichannel laser doppler system 
(Perimed, Stockholm, Sweden) that works on the principle of doppler shift. A beam 
of laser-generated monochromatic light is applied to the surface of tissue being 
studied via a fibre optic probe. Back-scattered light is picked up by sensitive photo 
detectors via a separate fibre in the probe. The returned signal is analyzed by the 
instrument giving a value of blood cell movement. The result presented as an 
arbitrary Perfusion Unit (PU) can be viewed on the instrument, on a chart recorder or 
using a computer with PeriSoft software. Since the PU is arbitrary, it cannot be given 
any physiological definition such as the actual number of cells flowing through a 
given volume of tissue during a given time period. Thus, periflux perfusion values 
must be compared relative to one another and are not absolute. The measuring 
depth in the skin means that only movements in micro vessels contribute to the 
value. In tissues other than skin, movement in large vessels passing near the 
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surface can influence the measurement. However, the thickness of large vessels is 
sufficient to exclude most of the laser light. The moving objects measured are mainly 
red blood cells but leucocytes and platelets also contribute. This technique has 
advantages of being non invasive or invasive depending on the tissue under study. 
 
Our results have shown a wide range of changes in the blood flow both around the 
heel prick site (n = 22) and in the contra-lateral foot (n = 29) after the procedure and 
the results were not statistically significant. Linear regression analysis in the peri-
heel prick group did not show any correlation between either the pre (baseline) skin 
blood flow (p = 0.816) or the post (peak levels) heel prick skin blood flow (p = 0.803) 
with gestational age. Also, there was no significant increase in skin blood flow post 
heel prick (p = 0.377). In the contra-lateral group our study showed a negative 
correlation between the pre (baseline) skin blood flow (p = 0.099) and the post (peak 
levels) heel prick skin blood flow (p = 0.084) with their gestational age. And there 
was a significant increase in skin blood flow in the contra-lateral limb post heel prick 
as compared to the pre (baseline) (p  = 0.0016**). However, this result needs to be 
interpreted with caution as seen the results could be skewed by a few readings. We 
then used the ratio of post / pre heel prick values to analyse the results with linear 
regressions fitted to test the relationship with gestational age. In neither set of 
measurements was the relationship statistically significant (p = 0.73, ipsilateral data; 
p = 0.67 contralateral data). So, for the Doppler changes, there is no evidence of a 
relationship to gestational age, but perhaps this is also confounded by other factors. 
 
As with the previous analysis, the major limitation of our study was a small sample 
size. Also, skin blood flow changes are dependent on the baseline skin temperature, 
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room temperature, baby’s cardiovascular status and post heel prick squeezing (in 
case of peri-heel prick recordings). They are also affected to a large extent my 
movements (movement artefacts). Hence, skin blood flow changes as measured 
with laser Doppler may not be useful to monitor response to pain as the results can 
be altered by many other factors. However, in order for the results to be interpreted 
with confidence, a much larger study group will have to be looked at. Whether the 
administration of sucrose to the babies could have altered our results would have 
been possible to ascertain by doing a subgroup analysis comparing babies who 
received sucrose with babies who did not receive any sucrose. This was not possible 
in our study since all babies received oral sucrose prior to heel prick as a part of unit 
protocol. 
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CHAPTER 6 
 
USE OF THE NOVEL CONTACT HEAT EVOKED POTENTIAL 
STIMULATOR (CHEPS) FOR THE ASSESSMENT OF PAIN IN 
NEONATES 
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6.1 INTRODUCTION 
 
6.1.1 EVOKED POTENTIALS IN PAIN RESEARCH 
 
6.1.1.1 DEFINITION 
 
EEG has been used to study pain since 1960s, especially the pain evoked potentials 
that offer an objective way of measuring pain. An evoked potential (EP) is an 
electrical potential recorded from the nervous system following presentation of a 
stimulus (Wikipedia ; Andrew S Blum 2007).  EPs test and record how quickly and 
completely the nerve signals reach the brain from the site of the stimulus and hence 
can be used to examine the functional integrity of somatosensory pathways.  An 
event-related potential (ERP) is a measured brain response that is directly the result 
of a thought or perception i.e. any stereotyped electrophysiological response to an 
internal or external stimulus as measured with EEG (Wikipedia ; Wikipedia ; Andrew 
S Blum 2007).  
 
There are three kinds of evoked potentials in clinical use (Wikipedia ; Andrew S Blum 
2007):  
1. Brain auditory evoked potentials (BAEP): generated by specific brain regions 
in response to stimulation of the auditory pathways. 
2. Visual evoked potentials (VEP): generated in the occipital cortex in response 
to visual stimulation. 
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3. Somatosensory evoked potentials (SSEP or SEP): generated by various 
portions of the ascending sensory pathways in response to stimulation of 
peripheral sensory nerves. 
 
6.1.1.2 PHYSIOLOGIC BASIS OF EVOKED POTENTIALS 
 
EP signals can be recorded from cerebral cortex, brain stem, spinal cord and 
peripheral nerves. EP surface electrodes record changes in extracellular voltage at 
the skin or scalp surface. When gray matter activity in the cortex or spinal cord is 
responsible for the main electrical generators of the recorded waveform, the evoked 
potential is termed a “near-field” potential and when the white matter tracts or 
subcortical structures are the main generators the evoked potential is called “Far-
field” potential.  
 
The components of an EP/ ERP are referred to by a letter indicating polarity of their 
voltage peak, followed by a number indicating either the latency to maximal 
amplitude after stimulation (measured in milliseconds) or the component's ordinal 
position in the waveform, e.g. a negative-going peak that is the first substantial peak 
in the waveform and often occurs about 100 milliseconds after a stimulus is 
presented is often called the N100 (indicating its latency) or N1 (indicating that it is 
the first peak and is negative); it is often followed by a positive peak usually called 
the P200 or P2. 
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Figure 6.1: Normal Evoked Potential waveform (Edwards et al. 2011) 
Evoked potential amplitudes tend to be low, ranging from less than a microvolt to 
several microvolts. Signal averaging can be done to resolve these low-amplitude 
potentials against the background of ongoing EEG, ECG, EMG and other biological 
signals and ambient noise.  
 
Because of their ease of stimulation, reliability of recording sites, and ample existent 
normative data, median nerve and posterior tibial nerve responses are most 
commonly used for recording SSEPs.  
 
6.1.1.3 EVOKED POTENTIALS IN NEONATAL PAIN  
 
SSEPs have been used in neonates to assess the functional integrity and maturity of 
the neural pathways. There is good evidence of recording SSEPs from 30 weeks 
gestation but not so good in babies less than 28 weeks (Klimach and Cooke 1988; 
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Pike, Marlow et al. 1997; Smith, Gitau et al. 2000). Some studies have even reported 
cortical SSEPs from as early as 25th week (Taylor, Boor et al. 1996). These studies 
have shown a decrease in the peak latency with increased gestational age (Klimach 
and Cooke 1988; Taylor, Boor et al. 1996; Smith, Gitau et al. 2000). The possible 
reasons postulated for not being able to record SSEPs in babies born at <28 weeks 
are technical difficulties in this age group and / or functional immaturity of the 
nervous system in premature infants (Slater, Fitzgerald et al. 2007). 
 
Most data on normative values for SSEPs have been obtained from adults. Median 
and posterior tibial nerve SSEPs can be recorded in infancy, although an 
incompletely developed nervous system renders markedly different recordings than 
those of adults. The validity of the median nerve SSEPs to predict 
neurodevelopmental outcomes especially in the preterm infants is not fully 
established (Mercuri, von Siebenthal et al. 1994; Majnemer and Rosenblatt 1996; 
Taylor, Boor et al. 1996; Ekert, Taylor et al. 1997). 
 
Amplitudes in evoked potential studies are highly variable and of limited clinical use. 
Araki et al (1998) in their study concluded that the amplitudes of the cortical 
components of SSEP in children are greatly influenced by the stimulus rate (Araki, 
Takada et al. 1999). N2-P2 amplitude differences have been used in adult studies in 
the assessment of pain (Carmon, Dotan et al. 1978; Carmon, Friedman et al. 1980; 
Bromm and Scharein 1982; Stowell 1985; Bromm and Lorenz 1998). 
 
A study done by Smit et al (2000) concluded that N1 latency reflects the functional 
integrity of the somatosensory pathway in the nervous system and can be affected 
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by conditions like intraventricular haemorrhages etc (Smith, Gitau et al. 2000). In 
their study, the observed N1 latency at term and at 6 months corrected age suggests 
that extra uterine maturation of the somatosensory pathway in infants born at less 
than 30 weeks' gestation is delayed by extra uterine life. However, Tombini et al 
(2008) concluded that extra uterine life does not affect maturation of somatosensory 
pathways in preterms without neurological deficit and hence SSEPs could be 
considered a useful tool for a non-invasive assessment of somatosensory pathways 
integrity in preterm infants (Tombini, Pasqualetti et al. 2009).  
 
Slater et al (2009) in their study showed the presence of a distinct nociceptive-
specific potential in newborn infants (Slater, Worley et al. 2010). The data show that 
noxious stimulation evokes distinct neuronal activity in the infant brain and that 
different somatosensory modalities can be discriminated and processed from an 
early age. The same group demonstrated that infants who are born prematurely and 
who have experienced at least 40 days of intensive or special care have increased 
brain neuronal responses to noxious stimuli compared to healthy newborns at the 
same postmenstrual age (Slater, Fabrizi et al. 2010). They showed that these 
noxious-evoked potentials are clearly distinguishable from shorter latency potentials 
evoked by non-noxious tactile sensory stimulation.  
 
6.1.2 CONTACT HEAT EVOKED POTENTIAL STIMULATOR STUDIES 
Heat evoked potentials have been used to study nociceptive pathways in adults for 
many years (Carmon, Mor et al. 1976; Bromm, Neitzel et al. 1983; Bromm and 
Treede 1984; Bromm and Treede 1987; Bromm and Treede 1987; Bromm and 
Treede 1991; Morley, Lau et al. 2005). Until recently most studies of thermally 
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evoked potentials were performed using laser stimulators that selectively excite Aδ 
and C nerve fibres (Bromm, Neitzel et al. 1983; Bromm and Treede 1984). Contact 
heat pain evoked potentials were first reported by Harkins and colleagues (Harkins, 
Price et al. 2000; Itskovich, Fei et al. 2000). 
Contact heat stimuli provide a more natural thermal activation than lasers, evoking 
both the sharp, pricking, first pain and slow burning second pain of natural thermal 
injury (Craig, Chen et al. 2000; Arendt-Nielsen and Chen 2003). In addition, long 
duration stimuli and large areas on stimulation can also be used (Arendt-Nielsen and 
Chen 2003). Contact heat evoked potentials were hard to elicit until recently because 
of the slow temperature rise and fall times of the equipment utilised.  This problem 
has been overcome with the use of a newly developed device, the contact heat 
evoked stimulator (CHEPS), using which heat pulses can be delivered rapidly with 
adjustable peak temperatures; thus the differential warm/ heat thresholds of 
receptors expressed by Aδ and C fibres can be stimulated. 
CHEPS offers important advantages for studying evoked potentials. It is easy to use 
in a clinical situation with a dedicated software program to run the system. The 
superficial burns or erythema sometimes associated with lasers are avoided. The 
protective eyewear (required for lasers) is unnecessary. It can be used in areas 
unsuitable for other diagnostic tests (e.g. skin biopsy) such as the face or glabrous 
skin. Repetitive stimulation or “wind-up” is possible, offering an additional clinical tool 
for the assessment of small sensory nerve fibre function.  CHEPS is also compatible 
with fMRI, increasing its range of application in the study of evoked potentials and 
brain activation. 
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The suitability of CHEPS has already been illustrated in assessing nociceptive 
pathways in adults, particularly neuropathic pain patients (Atherton, Facer et al. 
2007). Evoked potentials to warm temperature stimulus have not been recorded in 
neonates by any other investigators, but there is a large amount of data from adults, 
including published data from the Peripheral Neuropathy Unit. Furthermore, the 
feasibility of recording contact heat evoked potentials in the MRI environment  in 
adults has also been demonstrated (Craig, Chen et al. 2000; Ohara, Crone et al. 
2004; Qiu, Noguchi et al. 2006; Granovsky, Granot et al. 2008; Roberts, Papadaki et 
al. 2008). 
 
Instead of using high temperatures, we have used non-painful, warm (temperatures 
of 37°C) in our unblinded, pilot study.  
 
6.2 METHODS 
 
6.2.1 SUBJECTS 
 
A total of 9 recordings of contact warm evoked potentials using CHEPS were made 
in 7 babies whose gestational ages varied from 29+1 to 39 weeks, and who were 
between 4 and 37 days old (Appendix A, Table 6.1, page 104). 
 
6.2.2 CONTACT WARM EVOKED POTENTIALS RECORDING USING CHEPS 
 
Babies were studied in a cot or in an unhumidified incubator. We performed contact 
warm stimulation using the contact heat evoked stimulator (CHEPS). CHEPS has 
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been developed and produced by Medoc (Ramat Yishai, Israel). It has a heat foil 
thermode (Minco Products, Inc., Minneapolis, MN) with an area of 572.5mm² 
covered with a 25μm layer of thermo-conductive plastic (Kapton®, thermal 
conductivity of 0.1 - 0.35 W/m/K at 23 °C).  Two thermocouples are embedded 10μm 
within the conductive coating which contact the skin directly.  CHEPS has an 
adjustable, maximum temperature rise time of 70°C/sec and cooling rate 40°C/sec, 
with a baseline temperature of 32°C. Heat pulses are delivered rapidly in less 
than 300 milliseconds with adjustable peak temperatures. Thus the differential warm/ 
heat thresholds of receptors expressed by Aδ and C fibres can be stimulated.  
 
  
Image 6.1: CHEPS machine with the thermode 
 
We applied a set of twenty stimuli of 37°C over the lumbar spine area with an inter-
stimulus interval of 7 seconds. The thermode was moved after each stimulus to 
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avoid habituation. A repeat set of recordings was then done with the same settings 
with the thermode placed on the cervico-thoracic spine area. 
 
Electroencephalogram (EEG) was acquired from 6 electrodes (Fz, Cz, Pz, infra-
orbital EOG, reference electrode Fpz and ground TP9) and reported from Cz and Fz. 
Electrodes were contacted with Nuprep electrode gel and impedance maintained 
below 5kΩ. A sampling rate of 500 Hz was applied for recording. Online low and high 
pass filters (0.15 Hz and 100 Hz respectively) were also applied to the EEG data 
recorded. 
 
EEG data was analysed using dedicated software Vision Analyser Version 1.05.0002 
(Brain Products GmbH, Munich, Germany). Using the software, the baseline EEG 
data was filtered (low pass 0.5305 Hz, high pass 40 Hz). It was then segmented 
around the trigger input from CHEPS, corrected for ocular blinks using the Gratton 
and Coles correction algorithm, averaged (10 segments), and re-referenced to an 
average reference.  
 
During this period of monitoring, babies’ heart rate, respiratory rate and the oxygen 
saturations were also noted. None of the babies studied received any analgesic 
medication including opiates or inotropes. 
 
The protocol was approved by the ethics committee and written consent was taken 
from parents before the study. 
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Details of babies’ gestational age, postnatal age, birth weight, current weight and 
other clinical details were obtained from the Badger system (Electronic clinical record 
system). Gestational age was determined from antenatal ultrasound scans or from 
the maternal report of the last menstrual period (as obtained from the Badger). 
 
6.2.3 RESULTS 
 
Similar waveforms were noted in all the leads which were obscured by eye 
movement artefact. No definitive negative (N2) and positive (P2) peaks were 
identifiable in any of the leads (Figure 6.2).  
 
 
Figure 6.2 Sample warm evoked potential trace recorded from a baby and 
extracted from Cz (Note no identifiable N2 and P2) 
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Normally the latencies of heat evoked potentials are measured from the first 
definitive negative peak (N2), and the amplitude measured peak to peak (N2 to P2). 
However, it was not possible to measure the latencies or the amplitudes of the 
waveforms in any of our traces.  
 
6.3 DISCUSSION 
 
In adults, reliable and quantifiable heat evoked potentials have been produced with 
consistent peak latencies and amplitudes and with significant correlation to pain 
intensity scores (Chen, Xu et al. 2001; Le Pera, Valeriani et al. 2002). The suitability 
of CHEPS in adults has already been illustrated by several authors  (Craig, Chen et 
al. 2000; Ohara, Crone et al. 2004; Qiu, Noguchi et al. 2006; Atherton, Facer et al. 
2007; Granovsky, Granot et al. 2008; Roberts, Papadaki et al. 2008). However, this 
was not the case in our study. In our study we could not demonstrate any clear 
waveform patterns with definitive negative and positive peaks.  
 
A study done by another group previously also indicated that responses in cortical 
activity recorded by EEG are not useful for clinical assessment of infants’ responses 
to noxious stimuli (Norman, Rosen et al. 2008). In this study, painful stimuli induced 
changes in the EEG record which correlated with behavioural pain responses. 
However, these changes occurred mainly within the highest frequencies studied, 
were not consistently lateralized, and were more pronounced when the child was 
awake. Careful analysis suggested that a major part of these responses came from 
muscle activity rather than from cerebral cortex and were hence not reliable.  
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The reasons for not being able to demonstrate any definitive wave patterns could be 
multiple. Firstly, the temperature that we used in our study was only warm (37°C) 
instead of painful hot temperature as used by the previous investigators in adults. 
Any higher temperature could not be used in babies especially preterm because of 
ethical and clinical (fragile skin, risk of burns) reasons. Thus it is possible that this 
temperature may have not been enough to stimulate the heat thresholds of receptors 
expressed by Aδ and C fibres. Secondly, it is possible that the thermo receptors in 
newborn babies are not physiologically mature enough to recognise and transmit 
signals with a temperature stimulus of 37°C. Lastly, the responses seen in all the 
leads corresponded to the ocular responses (EOG). In other words, the waveforms 
identified probably represented ocular artefacts, illustrating the technical difficulties 
(lack of control of eye movements) in recording evoked potentials in babies. 
 
The major limitation of our study again was a small sample size. Again, whether the 
administration of sucrose to the babies could have altered our results would have 
been possible to ascertain by doing a subgroup analysis comparing babies who 
received sucrose with babies who did not receive any sucrose. This was not possible 
in our study since all babies received oral sucrose prior to heel prick as a part of unit 
protocol. 
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CHAPTER 7 
 
CONCLUSION 
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7.1 MAIN FINDINGS AND THEIR SIGNIFICANCE 
 
We investigated 48 babies using techniques that may evaluate the function of 
nociceptor-specific nerve fibres and central pain pathways, in comparison with 
currently used behavioural and physiological indicators. These techniques included 
“objective” physiological responses to procedural pain, such as skin axon-reflex 
vasodilatation (flare) responses, and novel contact cerebral evoked potentials in 
response to warm (non-painful) stimuli.  
 
Our study showed an increase in both mean baseline (pre or resting) and post heel 
prick sweat levels with the gestational age of babies. However, when comparing the 
mean pre heel prick levels with the mean post heel prick levels at all ages, there was 
no significant change. Our study has shown some evidence that the change in sweat 
measurements (post as a ratio of pre) are related to gestational age but that the pre-
heel prick results and perhaps the age of the baby are confounding factors in this 
relationship. Our study has shown definite palmar emotional sweating response in 
babies ≥ 36-37 weeks, which varied greatly with their state of arousal. The sweat 
levels were lowest with babies asleep and highest when crying. Previous studies 
(Harpin and Rutter 1982a; Harpin and Rutter 1982b) had shown a striking increase 
in sweat levels post heel prick, but our study failed to demonstrate this effect. Babies 
born ≤ 36 weeks showed only slight or no increase in palmar water loss post heel 
prick stimulus. The sweat levels did not vary significantly in the three groups based 
on birth weight as well. We conclude that the palmar sweat response reflects the 
emotional state and correlates with the state of arousal, but this response was not 
specific to pain. As palmar/ plantar sweat loss reflects the sympathetic response to 
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stress, it may not be a reliable tool in assessing pain in neonates.  Moreover, the 
wide range of sweat levels in various age groups makes it difficult to use sweat 
levels to monitor stress / pain response. 
 
In our study we could not demonstrate a clear relationship between the behavioural 
responses (as assessed using PIPP score) and an objective marker of stress 
(palmar sweat levels). Moreover, inter-observer variability was also noted in the 
PIPP scores. This demonstrates how difficult it can be to use a pain assessment 
score in a clinical setting (Neonatal Intensive Care Unit) especially if the babies are 
sick, in closed incubators, on ventilators or on various medications that could alter 
their neurological status. 
 
Our study has shown a wide range of changes in the blood flow both around the heel 
prick site and in the contra lateral foot after the procedure. We could not demonstrate 
any evidence of a relationship between skin blood flow and gestational age, but 
perhaps this could be confounded by other factors. Skin blood flow can be altered by 
changes in baseline skin temperature, room temperature, baby’s cardiovascular 
status and post heel prick squeezing (in case of peri-heel prick recordings) and is 
subject to movement artefacts. Hence, skin blood flow changes as measured with 
laser Doppler may not be useful to monitor response to pain.  
 
We recorded SSR in only one baby and hence would need a much larger sample in 
order to interpret the results with confidence, but it appeared that further studies 
were unlikely to show correlations with procedural pain. 
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In our study the waveforms identified with CHEPS stimuli probably represented 
ocular artefacts, and we could not demonstrate any clear waveform patterns in 
response to a temperature stimulus of 37°C. The reasons for this could be the 
temperature of 37°C failing to sufficiently stimulate thermo receptors (Aδ and C 
fibres), functional immaturity of these thermo receptors in newborns or the technical 
difficulties (eye movements) in recording evoked potentials in babies. Hence, future 
studies need to look at ways of controlling various parameters that may potentially 
produce artefacts and obscure the definitive waveforms.  
 
One of our study aims was to investigate whether drug and non-drug pain relief 
treatments given as part of routine clinical care have any effect on the above results. 
However we could not study this effect as all babies received oral sucrose (as a part 
of unit protocol) before the heel prick procedures. Babies enrolled for our study did 
not receive any other analgesics. Since all babies received sucrose prior to the heel 
prick testing, any subgroup analysis (sucrose vs. no sucrose) could not be done. 
Also, whether the administration of sucrose to the babies could have altered our 
results would have been possible to ascertain by doing a subgroup analysis 
comparing sucrose vs. no sucrose groups that was not possible in our study. 
 
The major limitation to our study was a very small sample size. This could be 
explained on the basis of three main reasons. Firstly, having approached 110 
parents for the study, only 56 consented (about 50%). Out of those, we could 
perform our studies on 48 babies only as rest of the babies were either discharged or 
transferred to other units before we could attempt any studies. The term ‘pain 
research’ itself creates anxiety and concerns amongst parents whose stress levels 
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are already very high due to the admission of their baby to the unit, explaining the 
low recruitment rate in our study. One of the main challenges that neonatal and 
paediatric research faces is consent.  Enrolment of children into studies requires 
informed consent of the parents. Previous studies have shown that the main barriers 
to the children’s recruitment into trials may be factors like parental misconceptions 
about perceived benefits & risks of research, randomisation etc (Nabulsi, Khalil et al. 
; Harth and Thong 1995; Stephenson and Walker 1996; Zupancic, Gillie et al. 1997; 
Langley, Halperin et al. 1998; Hayman, Taylor et al. 2001). Secondly, as we were 
performing different studies like sweat rate testing, evoked potentials etc at different 
periods of time, we could only study the babies whose parents had given consent at 
that particular time. So, perhaps focussing on only one study like evoked potentials 
for the duration of the project would have been a more sensible option. Finally, 
grouping of babies based on their gestational ages and further division based on 
postnatal ages reduced the sample sizes even further. Our pilot study has illustrated 
the difficulties one faces whilst doing studies in neonates. Factors like 
unpredictability of responses at different gestational and postnatal ages (related to 
the functional maturity of nervous system) and technical difficulties like lack of control 
over limb and body movements, ocular movements, state of arousal and electrical 
interference from the equipment used in intensive care settings make neonatal 
research challenging. Our study has also highlighted the difficulties that one 
encounters in a neonatal intensive care in using any pain assessment scores 
especially in babies who are in closed incubators, on respiratory support or with 
neurological impairment etc.  
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7.2 FUTURE DIRECTIONS 
 
Bedside non-invasive techniques like EEG, Event related potentials and NIRS have 
shown promising results in their usefulness to detect cortical activation related to 
painful events like heel pricks. However, further studies looking at their utility, 
feasibility and clinical significance during differing painful situations, including 
ongoing pain, and within varying populations are required. Large samples coming 
from multiple centres will allow robust analyses of the range of painful conditions 
using various assessment techniques as well as individual variability. 
 
The advances in techniques to assess pain in adults (like fMRI, Evoked potentials 
etc) have the potential to greatly advance the assessment of pain and its treatment 
in neonates. Since these tests do not rely on the co-operation of the subject; they are 
ideally suited for the assessment of neonates and “pre-verbal” children. These 
techniques can be adapted for use in neonates, and have the potential to advance 
the assessment of pain and its treatment in neonates and pre-verbal children. 
Simultaneous acquisition of fMRI images whilst recording evoked potentials to 
various painful procedures could be pivotal in our understanding of pain transmission 
in neonates.   
 
Further studies with a large cohort of babies in both preterm and term neonates and 
in well as well as sick neonates could confirm some of the data presented in this 
thesis, and make a contribution to the understanding of mechanisms of pain in 
neonates, and contribute to the development of ways of assessing and managing 
pain in this group of vulnerable population in a better way. A major challenge would 
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be to find out the best approaches to allow a smooth transmission of research 
findings to the bedside. 
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APPENDIX A – TABLES 
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Table 2.1:  Details of babies studied at for palmar sweat levels 
Gestation 
(weeks) 
Number 
of babies 
Number of 
measurements 
Postnatal age 
range in days 
Birth weight (Kg)      
Mean     Range 
37 or more 4 4        2-6 3.34 2.16-4.49 
34-36+6 3 4 1-13 1.78 1.45-2.0 
30-33+6 1 3 14-28 1.41 1.41 
24-29+6 4 7 2-43 1.02 0.8 - 1.13 
 
 
 
Table 2.2: Babies’ observations (range) during sweat rate recording 
 Temperature 
(°C) 
Heart Rate 
(per min) 
Respiratory 
Rate (per min) 
Oxygen saturation 
(%) 
Range 36.5-37.3 106-185 17-93 79-100 
 
 
 
 
 
 
 
 
 
 
98 
 
Table 2.3:  Palmar sweat levels in babies at various gestational ages 
 
 
 
Gestation 
(weeks) 
Post-natal 
age 
Baseline (Pre heel 
prick) 
Post heel prick 
Palmar water loss (g/m2 
per hour) 
Palmar water loss (g/m2 
per hour) 
Mean Mean Mean Range 
≥ 37  1st week 63.01 68.53 68.53 5-9 
2nd week - - -  
3rd week - - -  
>3 weeks - - -  
34-36+6 1st week 23.47 26.87 26.87 4-16 
2nd week 11.77 16.7 16.7 7 
3rd week - - -  
>3 weeks - - -  
30-33+6 1st week - - -  
2nd week 6.22 8 8 16 
3rd week 9.2 10 10 18 
>3 weeks 10.7 19.8 19.8 11 
24-29+6 1st week 11.7 10 10 5-17 
2nd week 14.8 18.45 18.45 6-18 
3rd week - - - - 
>3 weeks 25.6 33.6 33.6 6-9 
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Table 2.4: Palmar sweat levels in babies (baseline and post heel prick) in the 
three groups based on birth weight 
Baby groups Post natal ages Sweat levels in  g/m2 per hour 
Baseline (Pre heel prick) Post heel prick 
Mean Range Mean Range 
AGA 1st week 37.74 
 
8.5-109.6 
 
29.4 
 
7-97.2 
2nd week 9.38 
 
4.4-15.6 
 
12.41 
 
7-18.7 
 
3rd week 9.21 
 
6.4-10.1 
 
9.97 
 
7.6-11.9 
 
>3 weeks 20.22 
 
3.1-38.6 
 
28.8 
 
13.7-48.5 
 
SGA 1st week 30.16 
 
5.5-97.6 
 
36.28 
 
13.2-100.2 
 
2nd week 14.38 
 
6.3-24.9 
 
18.53 
 
11.7-24.4 
 
3rd week - - - - 
>3 weeks - - - - 
LGA 1st week 28.54 
 
15.2-33 
 
35.18 
 
33.9-36.1 
 
2nd week - - - - 
3rd week - - - - 
>3 weeks - - - - 
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Table 3.1 The Premature Infant Pain Profile, adapted from (Stevens, Johnston 
et al. 1996) 
Indicator Finding Points 
Gestational age ≥ 36 weeks 0 
 32-35+6 weeks 1 
 28-31+6 weeks 2 
 < 28 weeks 3 
Behavioural state Active/ awake, eyes open, facial movements 0 
 Quiet/ awake, eyes open, no facial movements 1 
 Active/ sleep, eyes closed, facial movements 2 
 Quiet/ sleep, eyes closed, no facial movements 3 
Heart rate maximum 0-4 beats/ min increase 0 
 5-14 beats/ min increase 1 
 15-24 beats/ min increase 2 
 ≥25 beats/ min increase 3 
Oxygen saturation minimum 0-2.4% decrease 0 
 2.5-4.9% decrease 1 
 5.0-7.4% decrease 2 
 7.5% decrease or more 3 
Brow bulge None (≤ 9% of time) 0 
 Minimum (10- 39% of time) 1 
 Moderate (40- 69% of time) 2 
 Maximum (≥70% of time) 3 
Eye squeeze None (≤ 9% of time) 0 
 Minimum (10- 39% of time) 1 
 Moderate (40- 69% of time) 2 
 Maximum (≥70% of time) 3 
Nasolabial furrow None (≤ 9% of time) 0 
 Minimum (10- 39% of time) 1 
 Moderate (40- 69% of time) 2 
 Maximum (≥70% of time) 3 
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Table 3.2 Illustrating babies’ details with the PIPP scores and mean sweat 
levels 
 
 
 
 
 
 
 
 
 
 
 
 
Reco
rding 
Baby’s 
CGA 
Day PIPP 
Score 1 
PIPP 
Score 2 
Mean 
PIPP 
Score 
Mean sweat in g/m2 per hour 
 
Baseline Post heel 
prick 
1 29+3 5 9  8  8.5 12.5 8.9 
2 31+4 35 10 7 8.5 32.6 30.74 
3 34+4 35 6 6 6 24.2 28.7 
4 32+5 43 5 4 4.5 20.01 39.75 
5 37 1 6 0 3 23 32.12 
6 38+4 2 1 0 0.5 79 97.6 
7 38+2 2 6 2 4 57.13 80.81 
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Table 5.1: Details of babies studied for ipsi-lateral recordings 
Gestation 
(weeks) 
Number 
of 
babies 
Number of 
measurements 
Postnatal age 
range in days 
Birth weight (Kg)      
Mean     Range 
≥37  1 1 8        - 2.97 
34-36+6 1 1 3        - 1.64 
30-33+6 5 5 5-19 1.36 1.16-1.5 
24-29+6 8 12 2 - 26 1.16 0.86-1.34 
 
 
Table 5.2: Details of babies studied for contra-lateral recordings 
Gestation 
(weeks) 
Number 
of 
babies 
Number of 
measurements 
Postnatal age 
range in days 
Birth weight (Kg)      
Mean     Range 
≥37  4 4 2-3 3.04 1.77-3.94  
34-36+6 - - - - - 
30-33+6 3 4 6-48 1.17 0.92-1.66 
24-29+6 6 19 2 - 77 1.02 0.67-1.46 
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Table 5.3: Babies’ observations (range) during blood flow recording 
Range Temperature 
(°C) 
Heart 
Rate 
(per 
min) 
Mean Blood 
Pressure 
(mm Hg) 
Respiratory 
Rate (per min) 
Oxygen 
saturation 
(%) 
Ipsi-
lateral  
36.5-37.1 131-158 38-39 31-76 90-100 
Contra-
lateral 
36.2-37.3 119-165 36-43 28-77 88-100 
 
 
 
Table 5.4: Skin blood flow changes in the ipsi-lateral foot 
Skin blood flow measured in PU Mean Range 
Pre heel prick 39.57 13.24-224.85 
Post end sampling 1 min 47.5 7.54-231 
Post end sampling 3 min 27.96 7.87-135.04 
Post end sampling 5 min 34.9 33.08-72.69 
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Table 5.5: Skin blood flow changes in the contra-lateral foot 
Skin blood flow measured in PU Mean Range 
Pre heel prick 66.24 11.81-750.86 
Post heel prick 1 min 98.8 8.76-999.97 
Post heel prick 3 min 102.94 17.27-999.97 
Post heel prick 5 min 56.04 17.52-189.03 
Post end sampling 1 min 104.04 11.11-999.97 
Post end sampling 3 min 67.95 7.14-333.62 
Post end sampling 5 min 75.61 5.62-579.04 
 
 
 
Table 6.1: Details of babies studied with CHEPS 
Gestational 
Age  
Corrected Gestational 
Age (on test date) 
Age (in 
days) 
Birth 
weight 
Current weight 
(on test date) 
29+1 30 6 1.3 Kg 1.3 Kg 
31+2 36+3 36 0.92 Kg 1.22 Kg 
29+4 31 10 1.46 Kg 1.46 Kg 
29+4 32 17 1.46 Kg 1.6 Kg 
32+3 33+5 9 1.57 Kg 1.57 Kg 
39 39+4 4 3.16 Kg 3.16 Kg 
29+2 33+4 30 1.2 Kg 1.54 Kg 
29+2 34+4 37 1.2 Kg 1.54 Kg 
31+2 34 19 1.63 Kg 1.87 Kg 
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APPENDIX B – ADDITIONAL ANALYSIS 
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PALMAR SWEAT RATE SUBGROUP ANALYSIS BASED ON GESTATIONAL 
AGE: 
 
Babies born at 24-29+6 weeks showed little variation in the palmar sweat loss in the 
first 3 weeks of life (Using Mann Whitney test, p = 1.0 with n = 2 in week 1, n = 2 in 
week 2, n = 0 in week 3 and n = 3 in week 4). This variation became slightly more 
pronounced as babies approached a corrected gestational age of 36 weeks (Figure 
2.1). 
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Figure 2.1 Mean sweat levels in g/m2 per hour pre (baseline) and post heel 
prick in babies born at < 30 weeks (Before & After plot showing individual 
mean readings) 
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Babies born at 30-33+6 weeks also showed minimal variations in the palmar water 
loss till the third week of life with the variation slightly more pronounced after 3 
weeks of life (Using Mann Whitney test, p = 0.7 with n = 0 in week 1, n = 1 in week 2, 
n = 1 in week 3 and n = 1 in week 4) (Figure 2.2). 
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Figure 2.2: Mean sweat levels in g/m2 per hour pre (baseline) and post heel 
prick in babies born at 30-33+6 weeks (Before & After plot showing individual 
mean readings) 
 
Babies born at 34-36+6 weeks showed only slight but definite increases in the 
palmar sweat loss in the first and second week of life. However, we could not 
perform any statistical tests because of low numbers (n = 3 in week 1, n = 1 in week 
2, n = 0 in week 3 and n = 0 in week 4) (Figure 2.3).  
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Figure 2.3: Mean sweat levels in g/m2 per hour pre (baseline) and post heel 
prick in babies born at 34-33+6 weeks (Before & After plot showing individual 
mean readings) 
 
Babies born at ≥ 37 weeks showed a definite palmar water loss with some increase 
post heel prick but the range was very wide (Figure 2.4). The increase in the palmar 
water loss post heel prick stimulus was not as striking as the previous studies 
(Harpin and Rutter 1982; Harpin and Rutter 1982). Moreover, sweat response in this 
age group correlated more with the state of arousal than with the heel prick stimulus. 
It was seen that the sweat rate was significantly higher in babies who were awake 
and distressed (crying as hungry) than babies who were asleep. This higher sweat 
rate in babies who were crying prior to heel prick did not change significantly after 
the heel prick and the levels came down after the babies settled down (Figure 2.4). 
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However, as with the previous group we could not perform any statistical tests 
because of low numbers (n = 4 in week 1, n = 0 in week 2, n = 0 in week 3 and n = 0 
in week 4). 
>37 weeks mean sweat levels
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Figure 2.4: Mean sweat levels in g/m2 per hour pre (baseline) and post heel 
prick in babies born at ≥37 weeks (Before & After plot showing individual mean 
readings) 
 
Case study (Figure 2.7):  
 
This is a continuous trace recording of the sweat levels pre heel prick (baseline) and 
post heel prick in a 2 day old baby who was born at 38 weeks. It was noted that the 
sweat levels started increasing with the onset of crying (which was independent of 
heel prick procedure) and started coming down as the baby stopped crying and 
settled down. 
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Figure 2.7: Sweat response recorded in a 2 day old baby born at 38 weeks  
(Arrows marking the start and end of crying) 
 
PALMAR SWEAT RATE SUBGROUP ANALYSIS BASED ON BIRTH WEIGHT 
 
In order to find out if there were any differences in the mean baseline and post heel 
prick sweat levels in babies with different birth weights, the babies were divided into  
three major groups: 
1. Appropriate for gestational age (AGA): Birth weight 10th-90th centile for 
gestational age 
2. Small for gestational age (SGA): Birth weight < 10th centile for gestational age 
3. Large for gestational age (LGA): Birth weight > 90th centile for gestational age 
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The mean sweat levels and the range for each weight group were calculated at 
different postnatal ages as before (grouped as 1st week, 2nd week, 3rd week and >3 
weeks). 
 
Our study did not show any difference in the mean sweat levels in the three groups. 
As seen in Table 2.4 (Appendix A, page 99), the mean sweat levels in the three 
groups at various postnatal ages were variable with no direct correlation with the 
heel prick procedure. 
 
Figure 2.8 illustrates the mean sweat levels (mean of all readings at different 
postnatal ages) in babies in the three groups. Although the mean sweat levels post 
heel prick  were higher than the levels before heel prick (baseline), there did not 
appear to be any statistically significant difference in mean sweat levels amongst the 
three groups i.e. AGA, SGA and LGA (Mann Whitney test, p = 0.4). 
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Figure 2.8: Mean baseline and peak sweat levels in AGA, SGA and LGA babies 
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